Utilization of Viral Vector Vaccines in Preparing for Future Pandemics.

Hofmeyer, Kimberly A; Bianchi, Katherine M; Wolfe, Daniel N

Hofmeyer, Kimberly A; Bianchi, Katherine M; Wolfe, Daniel N.

Afiliación

Hofmeyer KA; US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, Washington, DC 20201, USA.
Bianchi KM; US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, Washington, DC 20201, USA.
Wolfe DN; US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, Washington, DC 20201, USA.

Vaccines (Basel) ; 10(3)2022 Mar 12.

Article en En | MEDLINE | ID: mdl-35335068

Palabras clave

clinical trials; pandemic; vaccines; vectors; virus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google